Home

Sapna Srivastava

CIK 1569226 · last filed 2026-07-15

Sapna Srivastava is a corporate insider who has filed 34 SEC Form 4 insider transactions across 8 companies since 2015. The most recent filing, for NUVL, was dated Jul 15, 2026. Current disclosed insider exposure totals $1.2M across reported positions. 3 SEC filings were submitted jointly with Innoviva, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.21M

Companies

8

Total Filings

34

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
C/O MYOS CORPORATION
45 HORSEHILL ROAD, SUITE 106
CEDAR KNOLLS, NJ 07927
Related Filers
Innoviva, Inc. — 3 joint filings, latest 2024-06-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Nuvalent, Inc. (NUVL) Delisted Director 0 $123.96 $0 $0 7 2026-07-15
ALMS Director 3,553 $9.18 $32.6K $0 3 2026-07-02
AURA Director 38,500 $7.00 $269.3K $0 6 2026-06-15
Tourmaline Bio, Inc. (TRML) Delisted Director 0 $47.98 $0 $0 3 2025-10-28
INVA Director 44,096 $20.66 $911.0K $0 2 2024-06-20
SQZ Biotechnologies Co (SQZ) Delisted Director — $0.43 — $0 4 2023-06-15
Tourmaline Bio, Inc. (TALS) Delisted Director — $27.20 — $0 2 2023-06-14
MedAvail Holdings, Inc. (MYOS) Delisted Director — — — $0 1 2015-01-12

Recent Filings

34 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-15 Nuvalent, Inc. (NUVL) Delisted Mixed −8,590 -$638.1K EDGAR
2026-07-02 ALMS Grant (A) +3,553 $0 EDGAR
2026-06-18 Nuvalent, Inc. (NUVL) Delisted Grant (A) +3,444 $0 EDGAR
2026-06-15 AURA Grant (A) +15,000 $0 EDGAR
2025-10-28 Tourmaline Bio, Inc. (TRML) Delisted Mixed −518 $0 EDGAR
2025-08-01 ALMS Grant (A) — $0 EDGAR
2025-06-20 Nuvalent, Inc. (NUVL) Delisted Grant (A) +2,647 $0 EDGAR
2025-06-18 AURA Grant (A) +13,000 $0 EDGAR
2025-06-06 Tourmaline Bio, Inc. (TRML) Delisted Grant (A) — $0 EDGAR
2024-07-01 ALMS Mixed — $0 EDGAR
Showing 1–10 of 34
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.